The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex

被引:60
作者
Wentzell, LM [1 ]
Maxwell, A [1 ]
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
基金
英国惠康基金;
关键词
topoisomerase; supercoiling; ciprofloxacin;
D O I
10.1006/jmbi.2000.4266
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinolone drugs can inhibit bacterial DNA replication, via interaction with the type II topoisomerase DNA gyrase. Using a DNA template containing a preferred site for quinolone-induced gyrase cleavage, we have demonstrated that the passage of the bacteriophage T7 replication complex is blocked in vitro by the formation of a gyrase-drug-DNA complex. The majority of the polymerase is arrested approximately 10 bp upstream of this preferred site, although other minor sites of blocking have been observed. The ability of mutant gyrase proteins to arrest DNA replication in vitro has been investigated. Gyrase containing mutations in the A subunit at either the active-site tyrosine (Tyr122) or Ser83 (a residue known to be involved in quinolone interaction) failed to halt the progress of the polymerase. A low-level, quinolone-resistant mutation in the B subunit of gyrase showed reduced blocking compared to wild-type. We have demonstrated that DNA cleavage and replication blocking occur on similar time-scales and we conclude that formation of the cleavable complex is a prerequisite for polymerase blocking. Addition ally, we have shown that collision of the replication proteins with the gyrase-drug-DNA complex is not sufficient to render this complex irreversible and that further factors must be involved in processing this stalled complex. (C) 2000 Academic Press.
引用
收藏
页码:779 / 791
页数:13
相关论文
共 51 条
[1]   CAMPTOTHECIN-STABILIZED TOPOISOMERASE-I-DNA ADDUCTS CAUSE PREMATURE TERMINATION OF TRANSCRIPTION [J].
BENDIXEN, C ;
THOMSEN, B ;
ALSNER, J ;
WESTERGAARD, O .
BIOCHEMISTRY, 1990, 29 (23) :5613-5619
[2]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[3]   Crystal structure of the breakage-reunion domain of DNA gyrase [J].
Cabral, JHM ;
Jackson, AP ;
Smith, CV ;
Shikotra, N ;
Maxwell, A ;
Liddington, RC .
NATURE, 1997, 388 (6645) :903-906
[4]   BACTERIAL CHROMOSOME AND ITS MANNER OF REPLICATION AS SEEN BY AUTORADIOGRAPHY [J].
CAIRNS, J ;
SINSHEIMER, RL .
JOURNAL OF MOLECULAR BIOLOGY, 1963, 6 (03) :208-&
[5]   Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26 [J].
Catapano, CV ;
Carbone, GMR ;
Pisani, F ;
Qiu, J ;
Fernandes, DJ .
BIOCHEMISTRY, 1997, 36 (19) :5739-5748
[6]   DNA gyrase and topoisomerase IV on the bacterial chromosome: Quinolone-induced DNA cleavage [J].
Chen, CR ;
Malik, M ;
Snyder, M ;
Drlica, K .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 258 (04) :627-637
[7]   DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs [J].
Cove, ME ;
Tingey, AP ;
Maxwell, A .
NUCLEIC ACIDS RESEARCH, 1997, 25 (14) :2716-2722
[8]   DNA cleavage is not required for the binding of quinolone drugs to the DNA Gyrase - DNA complex [J].
Critchlow, SE ;
Maxwell, A .
BIOCHEMISTRY, 1996, 35 (23) :7387-7393
[9]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[10]   MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI .3. CONDITIONS REQUIRED FOR LETHALITY [J].
DEITZ, WH ;
COOK, TM ;
GOSS, WA .
JOURNAL OF BACTERIOLOGY, 1966, 91 (02) :768-&